Early research (Phase 1)Study completedNCT02106923
What this trial is testing
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets
Who this might be right for
Healthy
Boehringer Ingelheim 72